Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization

Trends in Molecular Medicine

Volumn 9, Issue 3, 2003, Pages 109-117

  Rabbany, Sina Y ^a   Heissig, Beate ^b   Hattori, Koichi ^b   Rafii, Shahin ^b  

^a HOFSTRA UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METALLOPROTEINASE; STEM CELL FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 1;

ANGIOGENESIS; BLOOD FLOW; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOBILIZATION; CELL PROLIFERATION; CELL TRANSPORT; ENZYME ACTIVATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MOLECULAR MECHANICS; ORGANOGENESIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY MECHANISM; REVASCULARIZATION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; STEM CELL; STRESS; TISSUE INJURY; TISSUE REVASCULARIZATION; TUMOR GROWTH; WOUND HEALING;

EID: 0037358570     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00021-2     Document Type: Review

References (74)

1. cip1/waf1. Science 287, 1804-1808
2. Phillips, R.L. et al. (2000) The genetic program of hematopoietic stem cells. Science 288, 1635-1640
3. Krause, D.S. et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369-377
4. Hattori, K. et al. (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193, 1005-1014
5. Takahashi, T. et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438
6. + endothelial precursor cells. Circ. Res. 88, 167-174
7. Peled, A. et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-851
8. Lemischka, I.R. et al. (1986) Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45, 917-927
9. Asahara, T. et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
10. Asahara, T. et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-228
11. Asahara, T. et al. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18, 3964-3972
12. Crisa, L. et al. (1999) Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94, 3928-3940
13. Orlic, D. et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705
14. Orlic, D. et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98, 10344-10349
15. Orlic, D. et al. (2001) Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. New York Acad. Sci. 938, 221-229
16. Kocher, A.A. et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436
17. Iwaguro, H. et al. (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105, 732-738
18. Kalka, C. et al. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 97, 3422-3427
19. Schatteman, G.C. et al. (2000) Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106, 571-578
20. Shi, Q. et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367
21. + bone marrow cells. Blood 95, 581-585
22. Sata, M. et al. (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8, 403-409
23. Otani, A. et al. (2002) Bone marrow derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8, 1004-1010
24. Grant, M.B. et al. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607 -612
25. Lyden, D. et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201
26. Reyes, M. et al. (2002) Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109, 337-346
27. Moore, M.A. (2002) Putting the neo into neoangiogenesis. J. Clin. Invest. 109, 313-315
28. Gehling, U.M. et al. (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95, 3106-3112
29. Marchetti, S. et al. (2002) Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J. Cell Sci. 115, 2075-2085
30. Davidoff, A.M. et al. (2001) Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin. Cancer Res. 7, 2870-2879
31. Hattori, K. et al. (2001) Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354-3360
32. + stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849
33. Heissig, B. et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109, 625-637
34. + cells on vascular endothelium under shear flow. J. Clin. Invest. 104, 1199-1211
35. Greenberg, A.W. et al. (2000) Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood 95, 478-486
36. Grabovsky, V. et al. (2000) Subsecond induction of α4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J. Exp. Med. 192, 495-506
37. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931-10934
38. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
39. Pepper, M.S. (1997) Manipulating angiogenesis. From basic science to the bedside. Arterioscler. Thromb. Vasc. Biol. 17, 605-619
40. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364
41. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674
42. Hanahan, D. (1997) Signaling vascular morphogenesis and maintenance. Science 277, 48-50
43. Bergers, G. et al. (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812
44. Leung, D.W. et al. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
45. Flamme, I. et al. (1995) Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev. Biol. 169, 699-712
46. Ferrara, N. et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442
47. Carmeliet, P. et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
48. Terman, B.I. et al. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586
49. Ortega, N. et al. (1997) Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am. J. Pathol. 151, 1215-1224
50. Shalaby, F. et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66
51. Matthews, W. et al. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. U. S. A. 88, 9026-9030
52. Clauss, M. et al. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271, 17629-17634
53. Mitola, S. et al. (1997) Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 90, 1365-1372
54. Barleon, B. et al. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343
55. Wang, H. and Keiser, J.A. (1998) Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ. Res. 83, 832-840
56. Brogi, E. et al. (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97, 469-476
57. Fong, G.H. et al. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70
58. Benjamin, L.E. and Keshet, E. (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. U. S. A. 94, 8761-8766
59. Benjamin, L.E. et al. (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165
60. Holash, J. et al. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998
61. Rafii, S. (2000) Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105, 17-19
62. + cells identifies a population of functional endothelial precursors. Blood 95, 952-958
63. Coffin, J.D. et al. (1991) Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev. Biol. 148, 51-62
64. Robert, B. et al. (1996) Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am. J. Physiol. 271, F744-F753
65. Caprioli, A. et al. (1998) Blood-borne seeding by hematopoietic and endothelial precursors from the allantois. Proc. Natl. Acad. Sci. U. S. A. 95, 1641-1646
66. Rafii, S. et al. (1995) Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann. Thorac. Surg. 60, 1627-1632
67. Lin, Y. et al. (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105, 71-77
68. Hashiyama, M. et al. (1996) Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells. Blood 87, 93-101
69. Ziegler, B.L. et al. (1999) KDR receptor: a key marker defining hematopoietic stem cells. Science 285, 1553-1558
70. Coussens, L.M. et al. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490
71. Butcher, E.C. and Picker, L.J. (1996) Lymphocyte homing and homeostasis. Science 272, 60-66
72. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314
73. Springer, T.A. (1995) Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57, 827-872
74. Lane, W.J. et al. (2000) Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96, 4152-4159